{"id":"https://openalex.org/W3033403632","doi":"https://doi.org/10.2147/ott.s219449","title":"Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data","display_name":"Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3033403632","doi":"https://doi.org/10.2147/ott.s219449","mag":"3033403632","pmid":"https://pubmed.ncbi.nlm.nih.gov/32606733","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7293382"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s219449","doi":"https://doi.org/10.2147/ott.s219449","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s219449","pdf_url":"https://www.dovepress.com/getfile.php?fileID=58669","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=58669","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017559837","display_name":"Yazeed Sawalha","orcid":"https://orcid.org/0000-0001-6355-3671","observed_orcids":["https://orcid.org/0000-0001-6355-3671"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yazeed Sawalha","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA"],"raw_orcid":"https://orcid.org/0000-0001-6355-3671","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kami Maddocks","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA"],"raw_orcid":"https://orcid.org/0000-0001-8519-8404","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017559837","https://openalex.org/A5024389256"],"corresponding_institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.9882,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.87237039,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"Volume 13","issue":null,"first_page":"5123","last_page":"5133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polatuzumab-vedotin","display_name":"polatuzumab vedotin","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-non-hodgkin-lymphoma","display_name":"relapsed/refractory non-Hodgkin lymphoma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cd79b","display_name":"CD79b","score":0.753000020980835},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8740000128746033},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9789999723434448},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":0.953000009059906},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9549999833106995},{"id":"https://openalex.org/keywords/b-cell-lymphoma-treatment","display_name":"B-cell lymphoma treatment","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8174179792404175},{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.7370234727859497},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.666487455368042},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.6514726281166077},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6231430768966675},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5712018609046936},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5629772543907166},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5321758389472961},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.519790530204773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5138583183288574},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5020718574523926},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.33110371232032776},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2586665451526642},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.21580585837364197},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16761204600334167},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/ott.s219449","doi":"https://doi.org/10.2147/ott.s219449","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s219449","pdf_url":"https://www.dovepress.com/getfile.php?fileID=58669","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7293382","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7293382","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmid:32606733","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32606733","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:62249d20e48547c38f042dfdefefe284","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/62249d20e48547c38f042dfdefefe284","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 13, Pp 5123-5133 (2020)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/54329","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/profile-of-polatuzumab-vedotin-in-the-treatment-of-patients-with-relap-peer-reviewed-article-OTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/ott.s219449","doi":"https://doi.org/10.2147/ott.s219449","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s219449","pdf_url":"https://www.dovepress.com/getfile.php?fileID=58669","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3033403632.pdf","grobid_xml":"https://content.openalex.org/works/W3033403632.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1785108662","https://openalex.org/W2041498582","https://openalex.org/W2050100708","https://openalex.org/W2069832110","https://openalex.org/W2089197481","https://openalex.org/W2120640322","https://openalex.org/W2127018518","https://openalex.org/W2140085064","https://openalex.org/W2318459925","https://openalex.org/W2561221972","https://openalex.org/W2742627598","https://openalex.org/W2797584152","https://openalex.org/W2891543930","https://openalex.org/W2891571059","https://openalex.org/W2925270992","https://openalex.org/W2934686121","https://openalex.org/W2946486395","https://openalex.org/W2962056638","https://openalex.org/W2972413013","https://openalex.org/W2984248069","https://openalex.org/W2984927918","https://openalex.org/W2985653147","https://openalex.org/W2985964434","https://openalex.org/W2988658399","https://openalex.org/W2991378102","https://openalex.org/W4206392988"],"related_works":["https://openalex.org/W4232044877","https://openalex.org/W2987159535","https://openalex.org/W2127018518","https://openalex.org/W3087383626","https://openalex.org/W4399157132","https://openalex.org/W3033631076","https://openalex.org/W4248317592","https://openalex.org/W3015776330","https://openalex.org/W4283218976","https://openalex.org/W3138338987"],"abstract_inverted_index":{"ABSTRACT:":[0],"Polatuzumab":[1],"vedotin":[2],"is":[3,27],"an":[4],"anti-CD79b":[5],"antibody":[6],"conjugated":[7],"to":[8,81],"monomethyl":[9],"auristatin":[10],"E":[11],"that":[12],"has":[13],"shown":[14],"significant":[15],"clinical":[16,47],"activity":[17],"in":[18,30,59,74],"follicular":[19],"and":[20,26,34,51,56,76,89,97,100,105],"diffuse":[21],"large":[22],"B-cell":[23,65],"lymphoma":[24],"(DLBCL)":[25],"currently":[28],"FDA-approved":[29],"combination":[31],"with":[32,38,64],"bendamustine":[33],"rituximab":[35],"for":[36],"patients":[37,63],"relapsed/refractory":[39],"DLBCL.":[40],"This":[41],"review":[42],"article":[43],"summarizes":[44],"data":[45],"from":[46,79],"trials":[48],"of":[49,62],"polatuzumab":[50,88],"discusses":[52],"its":[53],"current":[54],"role":[55],"future":[57],"directions":[58],"the":[60,85,94],"treatment":[61],"non-Hodgkin":[66],"lymphoma.":[67],"METHODS:":[68],"We":[69,91],"conducted":[70],"a":[71],"literature":[72],"search":[73],"PubMed":[75],"Google":[77],"Scholar":[78],"inception":[80],"January":[82],"2020,":[83],"using":[84],"following":[86],"terms:":[87],"CD79.":[90],"also":[92],"reviewed":[93],"package":[95],"insert":[96],"available":[98],"abstracts":[99],"posters":[101],"presented":[102],"at":[103],"national":[104],"international":[106],"meetings.":[107]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-06-12T00:00:00"}